DLA Piper (Canada) LLP is pleased to announce that Jamie Mills has joined the firm as a Partner in the Toronto office. Jamie has a highly regarded practice focussed on the litigation of patents, trademarks and copyrights.
Jamie has almost 30 years’ experience successfully advocating for clients with complex intellectual property litigation before the Supreme Court of Canada, the Ontario Courts, the Federal Courts, the Patented Medicine Prices Review Board, the Trademarks Opposition Board and the Patent Appeal Board. Jamie also advises clients with respect to pharmaceutical pricing, pharmaceutical regulatory law, and government relations for the pharmaceutical and biopharmaceutical industries.
Jamie is a frequent speaker on intellectual property litigation, in particular with regard to pharmaceutical and biotechnology related matters and has been recognized for his considerable background in these areas by leading lawyer ranking guides Chambers and Partners, The Legal 500, The Best Lawyers in Canada, The Canadian Legal Lexpert Directory, IAM Patent 1000 and Managing Intellectual Property. He was listed a Top 250 Life Sciences Patent Litigator, Top 250 Patent Litigator and Top 1000 Patent Practitioner in the world by Intellectual Asset Management Magazine. In 2017, Jamie was named a Fellow of the Litigation Counsel of America.
Jamie joins us from a leading Canadian law firm, where he was a partner since 2010.
“Jamie is a highly-regarded practitioner and an excellent addition to the Canadian firm,” said Robert Seidel, Q.C., Canada Managing Partner. “His impressive background in intellectual property litigation, combined with his knowledge of pharmaceutical and biotechnology related matters, will be welcomed not only by our Intellectual Property group but by the firm as a whole.”